terça-feira, 6 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Via News Knowledge File

Palantir Technologies Inc

organization80% conf.·synced Oct 6, 2026

Software company specializing in big data analytics

60
sourced metrics
585
relationships
20
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week High
207.18USD
Oct 5, 2026reference only
Price 52 Week Low
107.27USD
Oct 5, 2026reference only
Stock Return Ytd
12.8%
Oct 5, 2026reference only
Market Cap
455108691800USD
Oct 5, 2026reference only
Stock Price
189.40USD
Oct 5, 2026reference only
Shares Outstanding
2402897000.0shares
Jun 30, 2026reference only
Revenue
1935464000.0USD
Jun 30, 2026reference only
Net Income
1061890000.0USD
Jun 30, 2026reference only
Operating Income
912004000.0USD
Jun 30, 2026reference only
Gross Profit
1638594000.0USD
Jun 30, 2026reference only
Cost Of Revenue
296870000.0USD
Jun 30, 2026reference only
Cash
2030047000.0USD
Jun 30, 2026reference only
Eps
0.41USD_per_share
Jun 30, 2026reference only
Total Liabilities
1793680000.0USD
Jun 30, 2026reference only
Stockholders Equity
9774194000.0USD
Jun 30, 2026reference only
Rd Expense
192513000.0USD
Jun 30, 2026reference only
Total Assets
11678564000.0USD
Jun 30, 2026reference only
Operating Cash Flow
899165000.0USD
Mar 31, 2026reference only

Stated objectives

2026 full-year revenue forecast

source
target: 7.18-7.20 billion by 2026-12-31 00:00:00stated

Full-year 2025 revenue target with 53% year-over-year growth

source
target: 4.398 billion USD by 2025-12-31 00:00:00stated

2026 revenue forecast

source
target: 7.18-7.20 billion USD by 2026-12-31 00:00:00stated

Achieve 70% revenue growth

source
target: 70% by 2026-12-31 00:00:00stated

Maintain mid-50% operating margins

source
target: mid-50% stated

Achieve approximately $7.2 billion in revenue for full-year 2026

source
target: 7.2 billion USD by 2026-12-31 00:00:00stated

Achieve roughly 61% revenue growth for full-year 2026

source
target: 61 percent by 2026-12-31 00:00:00stated

Achieve approximately $7.2 billion in revenue with 61% growth

source
target: 7.2 billion USD by 2026-12-31 00:00:00stated

2026 revenue guidance

source
target: 7.2 billion USD by 2026-12-31 00:00:00stated

2026 revenue growth rate

source
target: 61% by 2026-12-31 00:00:00stated

Relationship graph · 585 connections

Developed by
90
Competes with
89
Covered by
67
contracted by
61
Invested in
53
Supplies to
35
founded
26
Customer of
25
board member of
Peter Thiel
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com